Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment.
about
Cerebral small vessel disease: Capillary pathways to stroke and cognitive declineEarly brain injury, an evolving frontier in subarachnoid hemorrhage researchTransition of research focus from vasospasm to early brain injury after subarachnoid hemorrhageAdvances in the understanding of delayed cerebral ischaemia after aneurysmal subarachnoid haemorrhageNitric oxide suppresses cerebral vasomotion by sGC-independent effects on ryanodine receptors and voltage-gated calcium channelsTherapeutic implications of estrogen for cerebral vasospasm and delayed cerebral ischemia induced by aneurysmal subarachnoid hemorrhage.Nitric oxide-loaded echogenic liposomes for treatment of vasospasm following subarachnoid hemorrhage.Dopamine D2-receptor-mediated increase in vascular and endothelial NOS activity ameliorates cerebral vasospasm after subarachnoid hemorrhage in vitroInversion of neurovascular coupling by subarachnoid blood depends on large-conductance Ca2+-activated K+ (BK) channels.Jugular venous reflux and plasma endothelin-1 are associated with cough syncope: a case control pilot study.To look beyond vasospasm in aneurysmal subarachnoid haemorrhage.Simvastatin re-couples dysfunctional endothelial nitric oxide synthase in experimental subarachnoid hemorrhageHypothermia decreases cerebrospinal fluid asymmetric dimethylarginine levels in children with traumatic brain injury.Inhibition of cerebrovascular raf activation attenuates cerebral blood flow and prevents upregulation of contractile receptors after subarachnoid hemorrhage.Prehemorrhage statin use and the risk of vasospasm after aneurysmal subarachnoid hemorrhage.High dose erythropoietin increases brain tissue oxygen tension in severe vasospasm after subarachnoid hemorrhageReversible cerebral vasoconstriction syndrome: an under-recognized clinical emergency.Cerebral Vasospasm in Critically III Patients with Aneurysmal Subarachnoid Hemorrhage: Does the Evidence Support the Ever-Growing List of Potential Pharmacotherapy Interventions?Capillary transit time heterogeneity and flow-metabolism coupling after traumatic brain injury.Targeted over-expression of endothelin-1 in astrocytes leads to more severe brain damage and vasospasm after subarachnoid hemorrhage.Estradiol reduces ferrous citrate complex-induced NOS2 up-regulation in cerebral endothelial cells by interfering the nuclear factor kappa B transactivation through an estrogen receptor β-mediated pathwayAneuSearch: a software prototype for intracranial aneurysm searching and clinical decision support.Efficacy of Rho kinase inhibitor on cognitive impairment induced by chronic cerebral hypoperfusion in rats.Blood Metabolomic Predictors of 1-Year Outcome in Subarachnoid Hemorrhage.Pharmacological treatment of delayed cerebral ischemia and vasospasm in subarachnoid hemorrhage.Vasospasm after intraventricular hemorrhage caused by arteriovenous malformationRole of CT perfusion imaging in the diagnosis and treatment of vasospasm.The Beta-1-Receptor Blocker Nebivolol Elicits Dilation of Cerebral Arteries by Reducing Smooth Muscle [Ca2+]iTraumatic brain injury results in acute rarefication of the vascular network.Effects of common medications on cerebral vasospasm after subarachnoid haemorrhage.Bilirubin oxidation products (BOXes) and their role in cerebral vasospasm after subarachnoid hemorrhage.Role of calcitonin gene-related peptide in cerebral vasospasm, and as a therapeutic approach to subarachnoid hemorrhageDysfunction of nitric oxide synthases as a cause and therapeutic target in delayed cerebral vasospasm after SAH.Cerebral vasospasm pharmacological treatment: an updateIon channels and calcium signaling in cerebral arteries following subarachnoid hemorrhage.Oxyhemoglobin-induced expression of R-type Ca2+ channels in cerebral arteriesBilirubin oxidation products (BOXes): synthesis, stability and chemical characteristicsAlterations of caveolin-1 expression in a mouse model of delayed cerebral vasospasm following subarachnoid hemorrhage.Endothelial nitric oxide gene T-786C polymorphism and subarachnoid hemorrhage in Korean populationSignificance of C-reactive protein and transcranial Doppler in cerebral vasospasm following aneurysmal subarachnoid hemorrhage.
P2860
Q26776375-CE27BAC5-7D20-486E-9065-D5FB4C592A29Q26823982-54BD4EDE-CBE2-4DC5-BF7F-AD90EAAD9BE0Q26825343-EA3EA29F-9579-416F-9C96-67F199F22DBEQ27003355-6ECCFC50-A7B7-4D14-AF57-F924E10D19CBQ27345356-A0CCE46B-96A6-4E63-A4B0-9BE101B7B050Q30413885-65A54B3A-825E-427F-A65D-8A4510F79B6DQ30445314-00033AA6-166A-46DF-9656-4447E9E90CC8Q30490849-7DC78C46-A4B0-4077-A37B-14ABBA13F333Q30514232-7156A1EE-49D1-4D64-8A99-10E423A5E15AQ33162259-FB353055-69C4-4F58-B8DF-83B9B650A471Q33747387-05BBFCAB-F3BD-4FDA-880B-3FB244D165ECQ33836890-00362394-482B-4D36-9867-B7AC5B72CD6BQ34053465-D83F5E6D-F1E7-4F1A-9614-087E51BB4F1EQ34059987-032FED69-2B77-4CFF-B884-A5711AC0F656Q34271800-6F0D3F85-FEF4-498D-BD83-4E69EF7D650AQ34294255-9FF7A828-1B20-4D78-8A4B-4A219A733D25Q34409485-CCFCF598-736B-4F11-BF07-AE1069E545C2Q34612924-A2CA90EA-340A-4319-8393-CBA71267930EQ34727149-06656C30-DE30-4DB4-8981-7CAE9204B0DFQ35025799-9D3645A4-B81F-461B-B383-C091D6C4EA5BQ35078365-71CBDEC1-DDA8-4C1E-AB96-45FEE3784B58Q35138814-69233E34-4DDC-4AFE-940D-0B5DA3AC9031Q35480551-FBD548F5-65B5-484D-A245-7EA1A0C3FD19Q35558629-C593E865-D8B7-4E02-B33F-3F11E1BD5E51Q35574105-8E10DF93-B1C3-4270-A908-79263FF723B1Q35575170-7051CA16-8CF3-4347-A85F-94B82044A7CAQ36076511-B57123E8-9830-469C-BE24-1AF97FD97344Q36157478-C2164C07-B7F8-485C-B121-C9A6885E259AQ36319052-861F3260-F877-493E-8A01-514133B5DCC4Q36349732-752B7658-02C2-4574-8BB0-18D742807004Q36391810-3A19BB34-4F9E-43A8-85D5-97E6525D2086Q36400447-9E7DE44F-31DC-4BA1-91C9-C023BA623865Q36602684-17504CC8-641A-48F6-83BF-986DFE947B5BQ36610442-2DFB5E2B-6EDB-4EB4-9099-38B9FDEC4E59Q36681454-C91F3158-6E56-4319-B705-D01195325E35Q36969148-568FD7C4-C3A9-4248-90F1-AECD05159B83Q37262576-14E864B0-804C-4812-939C-AA16D9D0CD54Q37289479-11290034-BFEE-4395-A77A-94C8EA341359Q37292317-310DB420-F2AF-4882-BED9-D4E7A0F1327DQ37344652-50F16185-E38A-4427-BFC0-59C830C761CA
P2860
Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Delayed cerebral vasospasm and ...... hesis, and proposed treatment.
@ast
Delayed cerebral vasospasm and ...... hesis, and proposed treatment.
@en
type
label
Delayed cerebral vasospasm and ...... hesis, and proposed treatment.
@ast
Delayed cerebral vasospasm and ...... hesis, and proposed treatment.
@en
prefLabel
Delayed cerebral vasospasm and ...... hesis, and proposed treatment.
@ast
Delayed cerebral vasospasm and ...... hesis, and proposed treatment.
@en
P1476
Delayed cerebral vasospasm and ...... hesis, and proposed treatment.
@en
P2093
Ryszard M Pluta
P356
10.1016/J.PHARMTHERA.2004.10.002
P577
2005-01-01T00:00:00Z